pubmed-article:15289368 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15289368 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:15289368 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:15289368 | lifeskim:mentions | umls-concept:C0205476 | lld:lifeskim |
pubmed-article:15289368 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:15289368 | lifeskim:mentions | umls-concept:C0206461 | lld:lifeskim |
pubmed-article:15289368 | lifeskim:mentions | umls-concept:C1861172 | lld:lifeskim |
pubmed-article:15289368 | lifeskim:mentions | umls-concept:C1708528 | lld:lifeskim |
pubmed-article:15289368 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:15289368 | pubmed:dateCreated | 2004-8-17 | lld:pubmed |
pubmed-article:15289368 | pubmed:abstractText | Considerable variability exists in the use of pharmacological thromboprophylaxis among acutely ill medical patients, partly because clinically relevant end points have not been fully assessed in this population. We undertook an international, multicenter, randomized, double-blind, placebo-controlled trial using clinically important outcomes to assess the efficacy and safety of dalteparin in the prevention of venous thromboembolism in such patients. | lld:pubmed |
pubmed-article:15289368 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15289368 | pubmed:language | eng | lld:pubmed |
pubmed-article:15289368 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15289368 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:15289368 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15289368 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15289368 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15289368 | pubmed:month | Aug | lld:pubmed |
pubmed-article:15289368 | pubmed:issn | 1524-4539 | lld:pubmed |
pubmed-article:15289368 | pubmed:author | pubmed-author:VaitkusPaul... | lld:pubmed |
pubmed-article:15289368 | pubmed:author | pubmed-author:LeizoroviczAl... | lld:pubmed |
pubmed-article:15289368 | pubmed:author | pubmed-author:CohenAlexande... | lld:pubmed |
pubmed-article:15289368 | pubmed:author | pubmed-author:GoldhaberSamu... | lld:pubmed |
pubmed-article:15289368 | pubmed:author | pubmed-author:TurpieAlexand... | lld:pubmed |
pubmed-article:15289368 | pubmed:author | pubmed-author:OlssonCarl-Gu... | lld:pubmed |
pubmed-article:15289368 | pubmed:author | pubmed-author:PREVENT... | lld:pubmed |
pubmed-article:15289368 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:15289368 | pubmed:day | 17 | lld:pubmed |
pubmed-article:15289368 | pubmed:volume | 110 | lld:pubmed |
pubmed-article:15289368 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15289368 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15289368 | pubmed:pagination | 874-9 | lld:pubmed |
pubmed-article:15289368 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:meshHeading | pubmed-meshheading:15289368... | lld:pubmed |
pubmed-article:15289368 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15289368 | pubmed:articleTitle | Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. | lld:pubmed |
pubmed-article:15289368 | pubmed:affiliation | Unité de Pharmacologie Clinique, Université Claude Bernard Lyon I, Lyon, France. al@upcl.univ-lyon1.fr | lld:pubmed |
pubmed-article:15289368 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15289368 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:15289368 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:15289368 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:15289368 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:15289368 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289368 | lld:pubmed |